Most cases of bullous and non-bullous impetigo resolve without requiring medical care.[25]Hoffmann TC, Peiris R, Glasziou P, et al. Natural history of non-bullous impetigo: a systematic review of time to resolution or improvement without antibiotic treatment. Br J Gen Pract. 2021;71(704):e237-42.
https://www.doi.org/10.3399/bjgp20X714149
http://www.ncbi.nlm.nih.gov/pubmed/33558328?tool=bestpractice.com
Standard treatment for local disease with no systemic manifestations is with topical antibiotics.[26]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com
Oral antibiotics are reserved for patients with more severe or treatment-refractory disease.[24]National Institute for Health and Care Excellence. Impetigo: antimicrobial prescribing. Feb 2020 [internet publication].
https://www.nice.org.uk/guidance/ng153
[27]Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
https://www.doi.org/10.1093/cid/ciu444
http://www.ncbi.nlm.nih.gov/pubmed/24973422?tool=bestpractice.com
[28]Kwak YG, Choi SH, Kim T, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017 Dec;49(4):301-25.
https://www.icjournal.org/DOIx.php?id=10.3947/ic.2017.49.4.301
http://www.ncbi.nlm.nih.gov/pubmed/29299899?tool=bestpractice.com
Intranasal antibiotics are used for those with chronic nasal carriage of causative bacteria. Skin hygiene measures and the use of antiseptic agents that reduce pathogenic bacteria density on the skin are useful for most patients.
Skin that has been broken either by minor trauma or as a result of another condition is particularly susceptible to infection, therefore any underlying cause (including wounds, dermatitis, insect bites, and scabies) should be excluded and treated.[1]Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014 Aug 15;90(4):229-35.
https://www.aafp.org/afp/2014/0815/p229.html
http://www.ncbi.nlm.nih.gov/pubmed/25250996?tool=bestpractice.com
Neonates
Undertake antibiotic treatment in neonates in collaboration with a paediatric dermatologist or infectious disease specialist.
Patients presenting in the first month of life with non-bullous impetigo require oral antibiotics if MRSA is excluded or unlikely. Erythromycin is recommended as first-line treatment. Intravenous vancomycin is recommended if testing indicates the presence of MRSA.[26]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com
[29]Wallin TR, Hern HG, Frazee BW. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008 May;26(2):431-55.
http://www.ncbi.nlm.nih.gov/pubmed/18406982?tool=bestpractice.com
For neonates with bullous impetigo, parenteral antibiotic therapy with nafcillin, oxacillin, or clindamycin is recommended; vancomycin is recommended for cases of MRSA.[26]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com
[29]Wallin TR, Hern HG, Frazee BW. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008 May;26(2):431-55.
http://www.ncbi.nlm.nih.gov/pubmed/18406982?tool=bestpractice.com
Adults, children, and infants: superficial or limited infection
These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or haematogenous spread (fever, constitutional symptoms). National Institute for Health and Care Excellence (NICE) guidelines in the UK recommend hydrogen peroxide cream as a first-line treatment.[24]National Institute for Health and Care Excellence. Impetigo: antimicrobial prescribing. Feb 2020 [internet publication].
https://www.nice.org.uk/guidance/ng153
Topical antibiotics such as mupirocin, fusidic acid, retapamulin, and ozenoxacin should be used if hydrogen peroxide cream is unsuitable (e.g., if impetigo is around eyes) or ineffective, except where there is resistance.[26]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com
[27]Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
https://www.doi.org/10.1093/cid/ciu444
http://www.ncbi.nlm.nih.gov/pubmed/24973422?tool=bestpractice.com
[28]Kwak YG, Choi SH, Kim T, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017 Dec;49(4):301-25.
https://www.icjournal.org/DOIx.php?id=10.3947/ic.2017.49.4.301
http://www.ncbi.nlm.nih.gov/pubmed/29299899?tool=bestpractice.com
[30]Vogel A, Lennon D, Best E, et al. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. N Z Med J. 2016 Oct 14;129(1443):77-83.
http://www.ncbi.nlm.nih.gov/pubmed/27736855?tool=bestpractice.com
[31]Rosen T, Albareda N, Rosenberg N, et al. Efficacy and safety of ozenoxacin cream for treatment of adult and pediatric patients with impetigo: a randomized clinical trial. JAMA Dermatol. 2018 Jul 1;154(7):806-13.
http://www.ncbi.nlm.nih.gov/pubmed/29898217?tool=bestpractice.com
[32]Gropper S, Albareda N, Chelius K, et al; Ozenoxacin in Impetigo Trial Investigators Group. Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial. Future Microbiol. 2014;9(9):1013-23.
http://www.ncbi.nlm.nih.gov/pubmed/25340832?tool=bestpractice.com
Adults, children, and infants: widespread cutaneous lesions
These patients have no evidence of deeper soft tissue involvement (abscess, cellulitis) or haematogenous spread (fever, constitutional symptoms). The oral antibiotics dicloxacillin or flucloxacillin, erythromycin, or a first-generation cephalosporin (e.g., cefalexin) are preferred agents.[24]National Institute for Health and Care Excellence. Impetigo: antimicrobial prescribing. Feb 2020 [internet publication].
https://www.nice.org.uk/guidance/ng153
[27]Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
https://www.doi.org/10.1093/cid/ciu444
http://www.ncbi.nlm.nih.gov/pubmed/24973422?tool=bestpractice.com
Immunocompromised patients are at greater risk for developing a complicated course of infection; parenteral antibiotic treatment is a consideration for patients with widespread lesions and severe immune compromise.[26]Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012 Jan 18;(1):CD003261.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003261.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/22258953?tool=bestpractice.com
[29]Wallin TR, Hern HG, Frazee BW. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008 May;26(2):431-55.
http://www.ncbi.nlm.nih.gov/pubmed/18406982?tool=bestpractice.com
If MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing, appropriate antibiotic choices include clindamycin, trimethoprim/sulfamethoxazole, or doxycycline.[27]Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
https://www.doi.org/10.1093/cid/ciu444
http://www.ncbi.nlm.nih.gov/pubmed/24973422?tool=bestpractice.com
[28]Kwak YG, Choi SH, Kim T, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Infect Chemother. 2017 Dec;49(4):301-25.
https://www.icjournal.org/DOIx.php?id=10.3947/ic.2017.49.4.301
http://www.ncbi.nlm.nih.gov/pubmed/29299899?tool=bestpractice.com
[33]Bowen AC, Tong SY, Andrews RM, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014 Dec 13;384(9960):2132-40.
http://www.ncbi.nlm.nih.gov/pubmed/25172376?tool=bestpractice.com
Adults, children, and infants: deep soft tissue involvement or haematogenous spread
These patients present with more extensive skin disease (abscess, cellulitis) or evidence of haematogenous spread (fever, constitutional symptoms). Parenteral antibiotic therapy with nafcillin, oxacillin, or clindamycin is recommended.[34]Sartelli M, Coccolini F, Kluger Y, et al. WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections. World J Emerg Surg. 2022 Jan 15;17(1):3.
https://www.doi.org/10.1186/s13017-022-00406-2
http://www.ncbi.nlm.nih.gov/pubmed/35033131?tool=bestpractice.com
If MRSA is suspected (cases of spontaneous abscess or cellulitis; lesions that do not resolve with recommended antibiotic treatment) and/or determined by antibiotic susceptibility testing, vancomycin is the antibiotic of choice.[27]Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
https://www.doi.org/10.1093/cid/ciu444
http://www.ncbi.nlm.nih.gov/pubmed/24973422?tool=bestpractice.com
Alternatives to vancomycin include oritavancin, dalbavancin, and tedizolid. Consider collaboration with an infectious disease specialist (paediatric or adult) when treating infants, children, immunocompromised patients, or any patient poorly responsive to initial parenteral antibiotic treatment.
Intranasal antibiotics for chronic nasal bacterial colonisation
For patients who experience frequent recurrences of their impetigo, an intranasal antibiotic (applied to the nares at the same frequency as antibiotic skin application for 5 to 7 days of the month) is additionally used.[35]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication].
https://www.pcds.org.uk/clinical-guidance/impetigo
In the case where several family members other than the patient are affected by impetigo, intranasal antibiotic alone would be prescribed for the unaffected family member(s). In either case, the intention is to decrease nasal colonisation by bacteria, as the nasal reservoir can serve as a source for re-infection of an individual or spread of the infection to close contacts.
Skin hygiene measures
Twice-daily washing with soap and water is good general skin care for all patients with impetigo, as it helps to reduce the amount of bacteria on the skin. For older children and adults, particularly those with more widespread skin involvement, chlorhexidine can be a good antibacterial cleanser to add to their routine.[35]The Primary Care Dermatology Society. Impetigo. May 2022 [internet publication].
https://www.pcds.org.uk/clinical-guidance/impetigo
However, chlorhexidine is not recommended in neonates or children younger than 4 years (due to issues related to its potential toxicity with absorption).